Skip to main content

Table 2 Patient characteristics by study

From: The prognostic value of nestin expression in newly diagnosed glioblastoma: Report from the Radiation Therapy Oncology Group

Characteristics 7401
(n = 38)
7918
(n = 9)
8302
(n = 30)
8409
(n = 1)
9006
(n = 32)
9305
(n = 3)
9602
(n = 13)
9806
(n = 27)
Total
(N = 153)
Gender          
   Male 27 (71%) 4 (44%) 22 (73%) 1 (100%) 20 (63%) 1 (33%) 5 (38%) 18 (67%) 98 (64%)
   Female 11 (29%) 5 (56%) 8 (27%) 0 12 (38%) 2 (67%) 8 (62%) 9 (33%) 55 (36%)
Race          
   White 35 (92%) 8 (89%) 28 (93%) 1 (100%) 30 (94%) 3 (100%) 13(100%) 26 (96%) 144 (94%)
   Hispanic 2 (5%) 0 0 0 0 0 0 1 (4%) 3 (2%)
   Black 1 (3%) 1 (11%) 1 (3%) 0 2 (6%) 0 0 0 5 (3%)
   Other 0 0 1 (3%) 0 0 0 0 0 1 (1%)
Neuro. Function (Symptoms)          
   None/Minor 16 (42%) 3 (33%) 13 (43%) 0 23 (72%) 0 7 (54%) 19 (70%) 84 (54%)
   Moderate 13 (34%) 5 (56%) 16 (53%) 1 (100%) 9 (28%) 3 (100%) 6 (46%) 8 (30%) 59 (38%)
   Major/Severe 8 (21%) 1 (11%) 1 (3%) 0 0 0 0 0 11 (7%)
   Missing 1 (3%) 0 0 0 0 0 0 0 1 (1%)
KPS          
   ≤ 60 11 (29%) 1 (11%) 2 (7%) 0 1 (3%) 0 0 2 (7%) 17 (11%)
   70–80 13 (34%) 6 (67%) 19 (63%) 1 (100%) 12 (38%) 0 6 (46%) 10 (37%) 67 (44%)
   90–100 14 (37%) 2 (22%) 9 (30%) 0 19 (59%) 3 (100%) 7 (54%) 15 (56%) 69 (45%)
Prior Surgery          
   Biopsy 5 (13%) 0 1 (3%) 0 1 (3%) 0 0 3 (11%) 10 (7%)
   Part. Resect. 21 (55%) 5 (56%) 22 (73%) 1 (100%) 15 (47%) 1 (33%) 10 (77%) 15 (56%) 90 (59%)
   Tot. Resect. 11 (29%) 4 (44%) 7 (23%) 0 16 (50%) 2 (67%) 3 (23%) 8 (30%) 51 (33%)
   Unknown 1 (3%) 0 0 0 0 0 0 1 (4%) 2 (1%)
RPA          
   III 6 (16%) 1 (11%) 3 (10%) 0 7 (22%) 2 (67%) 4 (31%) 6 (22%) 29 (19%)
   IV 15 (39%) 3 (33%) 13 (43%) 1 (100%) 16 (50%) 1 (33%) 3 (23%) 11 (41%) 63 (41%)
   V 17 (45%) 5 (56%) 14 (47%) 0 9 (28%) 0 6 (46%) 10 (37%) 61 (40%)